全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Patient and Health System Factors Associated with First Line Tuberculosis Treatment Adherence, 2009-2014

DOI: 10.4236/jtr.2022.104017, PP. 220-229

Keywords: Adherence, First-Line, Tuberculosis, Treatment, Non-Adherence, Health System Factors, Patient

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: The prevalence and incidence rate of tuberculosis remains high although the disease is known to be almost always curable provided the patient adheres to the treatment regimen. This study assessed the strength of association between known patient and health system factors associated with first line tuberculosis treatment adherence. Methods: A quantitative cross sectional study. Retrospective chart reviews were conducted among 570 persons who had primary tuberculosis and received first line treatment at a health facility within the Nkangala district, Mpumalanga province and who had a treatment outcome recorded between 1st January 2009 and 31st December 2014. Adherence to first line tuberculosis treatment was defined as taking ≥80% of tuberculosis prescribed drugs within a period of 6 to 8 months. Stata software (logistic regressions model) was used to analyze results and find the strength of association between known factors and treatment adherence. Results: Out of the 570 study participants, 473 were adherent and 96 were not adherent. There was a statistically significant association between age 18 years and above (OR: 1.02, P-value: 0.027), sex (lower in males OR: 0.44, P-value: 0.001) and support (OR: 3.04, P-value: 0.05) and HIV (OR: 1, P-value: 0.634) and first line TB treatment adherence. Conclusion and Recommendation: >80% adherence to

References

[1]  World Health Organisation (2003) Adherence to Long Term Therapies: Evidence for Action. WHO, Geneva.
https://apps.who.int/iris/handle/10665/42682
[2]  Kunnath-Velayudhan, S., Salamon, H., Wang, H.-Y., Davidow, A.L., Molina, D.M., Huynh, V.T., et al. (2010) Dynamic Antibody Responses to the Mycobacterium Tuberculosis Proteome. Proceedings of the National Academy of Sciences, 107, 14703-14708.
https://doi.org/10.1073/pnas.1009080107
[3]  Naidoo, P., Dick, J. and Cooper, D. (2009) Exploring Tuberculosis Patients’ Adherence to Treatment Regimen and Prevention Programs at a Public Health Site. Qualitative Health Research, 19, 55-70.
https://doi.org/10.1177/1049732308327893
[4]  Jassal, M.S. and Bishai, W.R. (2010) Epidemiology and Challenges to the Elimination of Global Tuberculosis. Clinical Infectious Diseases, 50, 156-164.
https://doi.org/10.1086/651486
[5]  Zumla, A., Nahid, P. and Cole, S.T. (2013) Advances in the Development of New Tuberculosis Drugs and Treatment Regimens. Nature Reviews Drug Discovery, 12, 388-404.
https://doi.org/10.1038/nrd4001
[6]  National Department of Health (South Africa) (2007) National TB Infection Control Guidelines.
https://www.health.gov.za/tuberculosis
[7]  Naidoo, P., Peltzer, K., Louw, J., Matseke, G., Mchunu, G. and Tutshana, B. (2013) Predictors of Tuberculosis (TB) and Antiretroviral (ARV) Medication Non-Adherence in Public Primary Care Patients in South Africa: A Cross Sectional Study. BMC Public Health, 13, Article No. 396.
https://doi.org/10.1186/1471-2458-13-396
[8]  Bronner, L.E., Podewills, L.J., Peters, A., Somnath, P., Nshuti, L., Van der Walt, M. and Mametja, L.D. (2012) Impact of Community Tracer Teams on Treatment Outcomes among Tuberculosis Patients in South Africa. BMC Public Health, 12, Article No. 621.
https://doi.org/10.1186/1471-2458-12-621
[9]  Atkins, S., Lewin, S., Ringsberg, K. and Thorson, A. (2012) Towards an Empowerment Approach in Tuberculosis Treatment in Cape Town, South Africa: A Qualitative Analysis of Programmatic Change. Global Health Action, 5, Article 14385.
https://doi.org/10.3402/gha.v5i0.14385
[10]  Calver, A.D., Falmer, A.A., Murray, M., Strauss, O.J., Streicher, E.M., Hanekom, M., et al. (2010) Emergence of Increased Resistance and Extensively Drug-Resistant Tuberculosis Despite Treatment Adherence, South Africa. Emerging Infectious Diseases, 16, 264-271.
https://doi.org/10.3201/eid1602.090968
[11]  World Health Organization (2013) Global Tuberculosis Control: Surveillance, Planning, Financing. WHO, Geneva.
http://www.who.int/tb/publications/global_report/en
[12]  Brust, J.C., Shah, N.S,. Scott, M., Chaiyachati, K., Lygizos, M., Van der Merwe, T.L., et al. (2012) Integrated, Home-Based Treatment for MDR-TB and HIV in Rural South Africa: An Alternate Model of Care. The International Journal of Tuberculosis and Lung Disease, 16, 998-1004.
https://doi.org/10.5588/ijtld.11.0713
[13]  Lutge, E., Lewin, S., Volmink, J., Friedman, I. and Lombard, C. (2013) Economic Support to Improve Tuberculosis Treatment Outcomes in South Africa: A Pragmatic Cluster-Randomized Controlled Trial. Trials, 14, Article No. 154.
https://doi.org/10.1186/1745-6215-14-154
[14]  Uwimana, J., Jackson, D., Hausler, H. and Zarowsky, C. (2012) Health System Barriers to Implementation of Collaborative Tuberculosis and HIV Activities Incuding Prevention of Mother to Child transmission in South Africa. Tropical Medicine & International Health, 17, 658-665.
https://doi.org/10.1111/j.1365-3156.2012.02956.x
[15]  Brust, J.C.M., Gandhi, N.R., Carrara, H., Osburn, G. and Padayatchi, N. (2011) High Treatment Failure and Default Rates for Patients with MDR TB in KwaZulu-Natal, South Africa, 2000-2003. The International Journal of Tuberculosis and Lung Disease, 14, 413-419.
[16]  Cramm, J.M., Van Exel, J., Møller, V. and Finkenflügel, H. (2010) Participants View on Determinants of Compliance with Tuberculosis Treatment in the Eastern Cape, South Africa: An Application of Q-Methodology. The Patient: Patient-Centered Outcomes Research, 3, 159-172.
https://doi.org/10.2165/11531900-000000000-00000
[17]  Cramm, J.M., Finkenflugel, H.J.M., Moller, V. and Neiboer, A.P. (2010) TB Treatment Initiation and Adherence in a South African Community Influenced more by Perception than By Knowledge of Tuberculosis. BMC Public Health, 10, Article No. 72.
https://doi.org/10.1186/1471-2458-10-72
[18]  Gebremariam, M.K., Bjune, G.A. and Frich, J.C. (2010) Barriers and Facilitators of Adherence to Tuberculosis Treatment in Patients on Concomitant TB and HIV Treatment: A Qualitative Study. BMC Public Health, 10, Article No. 651.
https://doi.org/10.1186/1471-2458-10-651
[19]  Mazinyo, E.W., Kim, L., Masuku, S., Lancaster, J.L., Odendaal, R., Uys, M., Podewils, L.J. and Van der Walt, M.L. (2016) Adherence to Concurrent Tuberculosis Treatment and Antiretroviral Treatment among Co-Infected Persons in South Africa, 2008-2010. PLOS ONE, 11, e0159317.
https://doi.org/10.1371/journal.pone.0159317
[20]  Nkangala District Municipality (2015) Nkangala District Municipality.
https://www.nkangaladm.gov.za/
[21]  Republic of South Africa, Department of Health (2015) Nkangala Clinic Directory (Health services).
http://www.mpuhealth.gov.za/
[22]  Mpumalanga Province of AIDS Council (2016) Annual Progress Report 2014/15. Provincial Strategic Plan 2012-2016.
https://sanac.org.za/
[23]  G*Power 3. Statistical Power Analyses for Mac and Windows.
https://www.psychologie.hhu.de/arbeitsgruppen/allgemeine-psychologie-und-arbeitspsychologie/gpower
[24]  Vittinghoff, E., Glidden, D.V., Shiboski, S.C. and McCulloch, C.E. (2012) Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models. 2nd Edition, Springer, New York.
[25]  Hosmer, D.W., Lemeshow, S. and Sturdivant, R.X. (2013) Applied Logistics Regression. 3rd Edition, Wiley, Hoboken.
https://doi.org/10.1002/9781118548387
[26]  Klein, D.G. and Klein, M. (2010) Logistic Regression: A Self-Learning Text. 3rd Edition, Springer, New York.
[27]  Hilbe, J.M. (2009) Logistic Regression Models. Chapman and Hall/CRC, New York.
https://doi.org/10.1201/9781420075779

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133